Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

Share Price is delayed by 15 minutes
Get Live Data
24.05    -0.10 (-0.41%)
Bid:
23.95
Ask:
24.10
Spread: 0.15 (0.626%)
Market Cap: £447.59m
ENQ Live PriceLast checked at - London Stock Exchange

Intraday Enquest Share Chart

Form 8.5 (EPT/RI)-EnQuest plc

24 Apr 2025 11:07

RNS Number : 0684G
JPMorgan Securities Plc
24 April 2025
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

EnQuest plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Corporate Broker to Enquest Plc

(d) Date dealing undertaken:

23 April 2025

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes , Serica Energy plc

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

5p ordinary

Purchase

 

Sale

193,407

 

498,708

0.1430 GBP

 

0.1415 GBP

0.1382 GBP

 

0.1383 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

5p ordinary

Equity Swap

Decrease Long

 

Decrease Short

 

 

 

 

 

 

Increase Short

 

882

 

12,361

223,018

28,353

21,400

16,313

26,253

 

22

21,493

0.1396 GBP

 

0.1383 GBP

0.1384 GBP

0.1393 GBP

0.1394 GBP

0.1407 GBP

0.1415 GBP

 

0.1384 GBP

0.1396 GBP

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

24 April 2025

Contact name:

Hetvi Shah

Telephone number:

44 2034 936359

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERBZLFLEZLBBBE
Date   Source Headline
31st Oct 20189:38 amRNSTotal Voting Rights
24th Oct 201812:11 pmRNSDirector/PDMR Shareholding
23rd Oct 20184:47 pmRNSDirector/PDMR Shareholding
22nd Oct 20186:14 pmRNSResults of Rump Placing
22nd Oct 20187:00 amRNSResult of Rights Issue
4th Oct 20187:00 amRNSMagnus and Thistle Options exercised
2nd Oct 20183:12 pmRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSAdmission of Nil Paid Rights
1st Oct 20182:55 pmRNSResults of General Meeting
25th Sep 20187:00 amRNSSwedish Issue Price
24th Sep 20181:43 pmRNSDirector/PDMR Shareholding
7th Sep 20187:00 amRNSMagnus Acquisition and Rights Issue
7th Sep 20187:00 amRNSHalf-year Report
29th Aug 20187:00 amRNSKraken FPSO settlement agreement
31st Jul 20182:17 pmRNSNotice to holders of the Company's Retail Notes
7th Jun 201811:24 amRNSReport on Payments to Govts
24th May 20184:39 pmRNSResult of AGM
24th May 20187:00 amRNSOperations Update
27th Apr 20184:37 pmRNSDirector/PDMR Shareholding
24th Apr 20182:27 pmRNSDirector/PDMR Shareholding
19th Apr 20184:00 pmRNSNotice of AGM and Report & Accounts
29th Mar 20188:57 amRNSDirector/PDMR Shareholding
20th Mar 20187:00 amRNSFull Year Results
21st Feb 20183:56 pmRNSAdmission to Trading
19th Feb 20187:00 amRNSOperations Update
16th Feb 20184:51 pmRNSReplacement: Released in Error
15th Feb 20189:07 amRNSPublication of Final Terms
31st Jan 20187:00 amRNSAGREEMENT WITH BP ON THISTLE DECOMMISSIONING
29th Jan 201810:22 amRNSNotice to holders of the Company's Retail Notes
25th Jan 20183:34 pmRNSHolding(s) in Company
10th Jan 20183:59 pmRNSTotal Voting Rights
8th Jan 20187:00 amRNSBoard Appointment
11th Dec 20177:00 amRNSDirectorate Change
1st Dec 20177:00 amRNSCompletion of Acquisition
30th Nov 20177:00 amRNSOperational Update
26th Oct 20177:00 amRNSLiquidity enhanced by over $100 million
24th Oct 201710:51 amRNSAllotment and Listing of Shares
26th Sep 20173:02 pmRNSDirector/PDMR Shareholding
22nd Sep 201712:58 pmRNSPublication of a Prospectus
13th Sep 20173:48 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSBoard Appointment
7th Sep 20177:00 amRNSHalf Year Results
23rd Aug 20177:00 amRNSOperations update
31st Jul 20174:34 pmRNSNotice to holders of the Company's Retail Notes
29th Jun 20179:00 amRNSDirectorate Change
26th Jun 20177:00 amRNSKraken First Oil
21st Jun 20174:14 pmRNSReport on Payments to Govts
25th May 20174:44 pmRNSBoard Appointment
25th May 20174:39 pmRNSResult of AGM
25th May 20177:00 amRNSOperational Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.